Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 2, 1998

View Archived Issues

Hoechst, Rhone-Poulenc Merge In New Life-Sciences Company

Scotia Loses Foscan Deal With Boehringer Ingelheim

Antisoma Raising £10M To Push Cancer Treatment

Pharming To Close Farms, Move Animals After Ban

Researchers Uncover Clues To Macrophage Invasions

Chinese To Invest More In Human Genome Effort

BioDiscovery, Rhone-Poulenc Enter Deal For Insect Samples

BioChip Launches Product For Detecting DNA In Food

Panel: Human Embryo Research Deserves Funding

Opposition To GMO Foods Rising Despite Monsanto Try

Belgian Biotechnology Growing In Spite Of European Worries

German Biotech Leadership Worried By Elections' Yield

European Biotech Sector Growing Fast, Says Report

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...